Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Plus Therapeutics ( (PSTV) ) just unveiled an update.
On February 13, 2025, Plus Therapeutics entered into a Securities Purchase and Exchange Agreement with existing accredited investors, issuing secured convertible promissory notes and common stock purchase warrants totaling approximately $3.7 million. These financial instruments are secured by most of the company’s assets and come with various conversion options and covenants, indicating a strategic effort to manage financial obligations and leverage future financing opportunities. Additionally, the company announced a $2.0 million advance from the Cancer Prevention and Research Institute of Texas, which is part of a larger $17.6 million grant, highlighting a continued partnership in cancer research funding.
More about Plus Therapeutics
YTD Price Performance: 5.08%
Average Trading Volume: 48,034
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $7.31M
Learn more about PSTV stock on TipRanks’ Stock Analysis page.
